Post‐transplant cyclophosphamide limits reactive donor T cells and delays the development of graft‐versus‐host disease in a humanized mouse model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Post‐transplant cyclophosphamide limits reactive donor T cells and delays the development of graft‐versus‐host disease in a humanized mouse model

Published:2021-06-13 Issue:2 Volume:164 Page:332-347
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Adhikary Sam R.¹²^ORCID,Cuthbertson Peter¹²^ORCID,Nicholson Leigh³^ORCID,Bird Katrina M.¹²^ORCID,Sligar Chloe¹²^ORCID,Hu Min³⁴^ORCID,O'Connell Philip J.³^ORCID,Sluyter Ronald¹²^ORCID,Alexander Stephen I.⁵^ORCID,Watson Debbie¹²^ORCID

Affiliation:

1. Illawarra Health and Medical Research Institute Wollongong NSW Australia

2. Molecular Horizons and School of Chemistry and Molecular Bioscience University of Wollongong Wollongong NSW Australia

3. Westmead Institute for Medical Research Westmead NSW Australia

4. Faculty of Medicine and Health The University of Sydney Sydney NSW Australia

5. The Children's Hospital at Westmead Westmead NSW Australia

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13374

Reference64 articles.

1. The biology of graft-versus-host disease: experimental systems instructing clinical practice

2. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies

3. Alloreactive Memory T Cells Are Responsible for the Persistence of Graft-versus-Host Disease

4. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution

5. Shared biology of GVHD and GVT effects: Potential methods of separation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice;International Journal of Molecular Sciences;2024-02-01

2. Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice;Clinical & Translational Immunology;2024-01

3. Tocilizumab increases regulatory T cells, reduces natural killer cells and delays graft‐versus‐host disease development in humanized mice treated with post‐transplant cyclophosphamide;Immunology & Cell Biology;2023-05-16

4. Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells;iScience;2023-03

5. Insights into mechanisms of graft-versus-host disease through humanised mouse models;Bioscience Reports;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3